Navigation Links
Moleac Launches NeuroAid10(TM) in the United States
Date:3/6/2008

Supplement to help support Neurological Function Now Available in the US

SINGAPORE, March 6 /Xinhua-PRNewswire/ -- Singapore-based Moleac today launched a new product called NeuroAid10(TM) in the US market to support patients' neurological functions. NeuroAid10(TM) is derived from NeuroAid(TM) and is a combination of ten all-natural ingredients. Moleac is a global biopharmaceutical company that brings together the best of Asian and Western medicine.

Since its launch in 2000, NeuroAid(TM) has been used by 200,000 stroke survivors every year in Asia alone. In addition, a growing number of Americans have already started using NeuroAid(TM) regularly with positive results on their neurological functions.

The clinical data obtained with NeuroAid(TM) on recovery several months after a stroke has triggered large interest in the neurology community. In October 2007, enrollment began for a multi-center, double-blind, placebo- controlled, randomized trial. This aims to evaluate the efficacy of NeuroAid(TM) in reducing neurological deficit and improving independence in patients in rehabilitation, with treatment starting within 48 hours of a stroke. "The CHIMES Stroke Study is ground-breaking for the medical industry as the largest clinical trial on stroke recovery and the first time any TCM product has been assessed on this wide a scale outside China," said Professor Geoffrey Donnan, President World Stroke Organization, who chairs the study data and safety monitoring committee.

NeuroAid(TM) is already commonly used in several countries. "As we received an increasing number of requests from individuals in US to make NeuroAid(TM) available locally, we have engineered a new formulation which is marketed as Neuroaid10TMin the US, a dietary supplement to help support the neurological functions. NeuroAid10(TM) is an herbal natural dietary supplement, containing the 10 main ingredients of NeuroAid(TM), carefully selected and manufactured with the same stringent process as NeuroAid(TM)," said David Picard, CEO Moleac.

NeuroAid10(TM) is marketed in the US as an herbal dietary supplement with the indication to help support neurological functions.

Neurological functions involve the brain and the nervous system. The nervous system connects the entire human body, relaying information back and forth between the brain and the muscles, skin and key organs, allowing actions such as movement, and sensations such as pain. The smooth transmission of information between the brain and the rest of the body is therefore essential for daily activities such as walking, speaking or thinking, and can only occur when neurological functions are healthy and strong.

Ruth Lycke, a stroke survivor and the author of "Hope, Help and Healing", said, "I am thrilled to see NeuroAid10(TM) now available locally after having benefited myself from the treatment in China."

NeuroAid10(TM) does not contain any of the animal based ingredients of NeuroAid(TM) which were considered as secondary in the original formulation. "We will work with health authorities around the world to make NeuroAid(TM) available in international markets over the coming years," said Picard.

Moleac has now established a robust distribution system in the US with Suresource. The product can be purchased at http://www.neuroaid10.com or at http://www.amazon.com .

About NeuroAid10(TM)

NeuroAid10(TM) is a Dietary Supplement that provides support for neurological functions. It is a combination of ten all ingredients from the Chinese medicinal pharmacopoeia, formulated according to international Good Manufacturing Practice (GMP) standards. It is marketed internationally by Moleac. For more information visit http://www.neuroaid10.com or by calling +1-800-421-1223.

About Moleac

Moleac is a biopharmaceutical company based in the Republic of Singapore;. Moleac identifies promising medicines and develops them for broad distribution. Focusing on patients' greatest needs and specific unmet medical needs, Moleac drives research, development and registration for a pipeline of drugs and devices in various stages of development.

DISCLOSURE NOTICE: The information contained in this release is as of March 20,2008. Moleac assumes no obligation to update any forward-looking statements contained in this release as the result of new information or future events or developments. This release contains forward-looking information about the potential benefits of NeuroAid(TM) and NeuroAid10(TM) that involves substantial risks and uncertainties.

Contact:

Moleac

Tel: +65-6478-9431 or +1-203-404-8258

Email: news@moleac.net


'/>"/>
SOURCE Moleac
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. Novozymes Launches Enzyme to Reduce Acrylamide in Food
3. Enova Medical Launches Exos Corporation
4. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
5. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
6. ThirdBiotech Networking Group Launches
7. BioReliance Launches Next-Generation Genotoxicity Screening Service
8. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
9. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
10. Kingfisher Healthcare Launches Breakthrough Product in Europe
11. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... COLORADO SPRINGS, CO , March 29, 2017 /PRNewswire/ - Last year,s ... who support kratom are not the only efforts active to generate ... that substitute opiate based pharmaceutical drugs in the healthcare market place. ... Earlier this ... U.S. based developer and distributor of pharmaceutical and nutritional products, announced ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... to announce that Nerium International Mexico has been approved as an active member ... to achieve satisfaction and protection among distributers and consumers in relationship marketing. This ...
(Date:3/29/2017)... , March 29, 2017  Halozyme Therapeutics, ... oncology and drug-delivery therapies, today announced that an ... and Drug Administration voted 11 to 0 that ... skin) injection was favorable for patients in the ... lymphoma and chronic lymphocytic leukemia. The FDA action ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... is exhibiting in booth 513 at the Association of Community Cancer Centers (ACCC) ... March 29-31. , CANCERSCAPE unites key stakeholders from leading national organizations to ...
Breaking Biology Technology:
(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
(Date:2/21/2017)... ARMONK, N.Y. and PORTLAND, Ore. ... IBM ) and the Avamere Family of Companies (Avamere ... Care) today announced a six-month research study that will ... caregivers improve eldercare at senior living and health centers. ... facilities, Avamere hopes to gain insights into physical and ...
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
Breaking Biology News(10 mins):